The size of the Middle East and Africa catheters market is estimated to be growing at a healthy CAGR during the forecast period. The market is expected to experience promising growth due to the increasing burden of cardiovascular, neurological, and urological disorders, increasing use of minimally invasive procedures, and increasing demand for antimicrobial catheters.
The increase in chronic disorders has become the leading cause of death and morbidity worldwide. According to the World Health Organization, the number of deaths from cardiovascular disease has increased by more than 2.2 million since 2000, reaching nearly 9.5 million worldwide. The alarming number of heart deaths has led to an increase in the number of heart surgeries, which has increased the use of catheters in the market and is expected to accelerate the catheter market's growth rate in the Middle East and African region.
In addition, the increasing demand for minimally invasive procedures is expected to increase the demand for catheters in the market in this region. These procedures have increased patient preference for minimally invasive procedures, which is expected to support market growth. Therefore, with the increasing number of chronic surgeries performed due to the increase in chronic diseases, there is an increase in demand for catheters, which is further estimated to drive the market.
According to the Brain Aneurysm Foundation, around 5 million deaths worldwide are caused by brain aneurysms each year, and half of those people are 52 years of age or younger. Thus, with the increasing prevalence of neurovascular disorders, there is also an increasing use of neurovascular catheter devices.
In addition, favorable reimbursement policies and increased urinary disorders are the key factors leading to an increase in demand for urinary catheters.
Limiting factors in the market are the leakage associated with external type catheters, the discomfort associated with the use of catheters, low health expenditure in the Middle East and Africa, weak reimbursement policies in poor regions, in particular in Africa, the shame and stigma associated with the use of urinary catheters, etc. However, catheter-associated urinary tract infections (CAUTI) remain the main limiting factor in the Middle East and Africa catheter market.
In addition, the risks of the catheterization procedure such as air embolism, bleeding, heart attack, infection, and kidney damage are also expected to hamper the growth of the market. The high cost of the cardiac catheterization procedure is expected to hamper the growth of the catheter market in the region.
Impact of COVID-19 on the MEA catheters market:
Countries in the Middle East and Africa face economic and humanitarian challenges due to the growing incidence of COVID-19. They have responded to the epidemic by closing borders, ordering quarantines, avoiding interventions, surgical alternatives, and imposing a series of restrictions to keep people confined at home.
Preventive measures such as social distancing and confinement drastically reduce people's visits to health facilities which, in turn, hamper the growth of the catheter market in the Middle East and Africa. The pandemic has infected the Middle East and Africa regions because these regions do not have large catheter production units to meet the demands of the population.
This research report on the MEA catheters market has been segmented and sub-segmented into the following categories:
By Distribution Channel:
Geographically, the UAE catheters market is estimated to hold the most significant share in the MEA market during the forecast period and is driven by unprecedented improvements in the region's health infrastructure, with authorities focusing on improving their current health services.
In Africa, the catheter market is expected to have the highest CAGR in the coming years. Increasing chronic illness like cancer is leveling up the growth rate of the market.
KEY MARKET PLAYERS:
A few of the notable players in the MEA catheters market profiled in this report are Boston Scientific Corporation, Medtronic, Becton, Dickinson and Company, Abbott, B. Braun Melsungen AG, ConvaTec Group PLC, Coloplast Group, Cook Medical, Edwards Lifesciences Corporation, Johnson & Johnson Services, Merit Medical Systems, Stryker Corporation, Terumo Corporation, and Teleflex Incorporated.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com